Système cardiovasculaire - MedQual

84. Anonymous. HTA: diurétique en première ligne, même chez les diabétiques. La Revue Prescrire
2005;264:615.
85. SIGN. Hypertension in older people. Publication 49, January 2001. www.sign.ac.uk
86. ANAES Prise en charge des patients adultes atteints d'hypertension artérielle essentielle, avril 2000.
87. Walma E, Thomas S, Prins A et al. NHG-Standaard Hypertensie. Huisarts Wet 2003;46:435-49.
88. Appel L. The Verdict From ALLHAT-Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension
JAMA 2002;288:3039.
89. Rosendorff C, Black H, Cannon C et al. Treatment of hypertension in the prevention and management
of ischemic heart disease. Circulation Published online May 14, 2007.
90. Wiysonge C, Bradley H, Mayosi B et al. Beta-blockers for hypertension. Cochrane database of Systematic
reviews 2007, Issue 1. Art. No.: CD002003. DOI: 10.1002/14651858.CD002003.pub2.
91. Anonymous. Review: Atenolol may be ineffective for reducing cardiovascular morbidity or all-cause
mortality in primary hypertension. ACP Journal Club 2005;142:59. Evidence-Based Medicine
2005;10:74.
92. Carlberg B, Samuelsson O, Lindholm L. Atenolol in hypertension: is it a wise choice Lancet
2004;364:1684-1689.
93. Van den Born B, Brewster L, Koopmans R et al. Atenolol en metoprolol beide geschikt als -blokker voor
de behandeling van hypertensie. Ned Tijdschr Geneeskd 2005;149:1808-1809.
94. Elsik M. Should beta blockers remain first-line drugs for hypertension. Australian Prescriber 2007;30:5-7.
95. Van Bortel L. Is er nog plaats voor bètablokkers Tijdschr. Voor Geneeskunde 2007;63:342-346.
96. NHG-standaard. Cardiovasculair risicomanagement. Januari 2006. http://nhg.artsennet.nl.
97. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of
ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively
designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
Lancet 2000;356:1955-64.
98. Hansson L, et al. Randomised trial of old and new antihypertensive drugs in elderly patients:
cardiovascular mortality and morbidity the Swedish trial in old patients with hypertension(STOP)-2 study.
Lancet 1999;354:1751-1756. Commentary on: Kendall MJ. Conventional versus newer antihypertensive
therapies--a draw. Lancet 1999;354:1744-1745.
99. Black H, Elliott W, Grandits G et al, CONVINCE Research Group. Principal results of the Controlled Onset
Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289:2073-82. (+
Editoral: 2128-2131).
100. Steffen H. Use of calcium channel antagonists for the treatment of hypertension in the elderly. Drugs
Aging 2004;21:566-581.
101. Hansson L, Lindholm L, Niskanen L et al. Effect of angiotensin-converting-enzyme inhibition compared
with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril
Prevention Project (CAPPP) randomised trial. Lancet 1999;353:611-616.
102. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an Angiotensin-
Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients. N Engl J Med
2000;352:145-53.
103. Wing L, Reid C, Ryan P et al. Second Australian National Blood Pressure Study Group. A Comparison of
Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
N Engl J Med 2003;348:583-92.
104. Simpson K, Jarvis B. Lisinopril: a review of its use in congestive heart failure. Drugs 2000;59:1149-67.
105. Packer M, Poole-Wilson P, Armstrong P et al. Comparative effects of low and high doses of the
angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure.
ATLAS Study Group. Circulation 1999;100:2312-8.
106. Anonymous. Protection renale par des médicaments. Folia Pharmacotherapeutica 2003;30:10-3.
www.cbip.be
107. Lovell H. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with
microalbuminuria. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD002183. DOI:
10.1002/14651858.CD002183.pub2.
108. Sowers J. Treatment of hypertension in patients with diabetes. Arch Int Med 2004;164:1850-1857.
109. Diabetes Type 1 and 2 – hypertension. Prodigy guidance 2006.
http://www.cks.library.nhs.uk/diabetes_hypertension
110. Dahlof B, Devereux R, Kjeldsen S et al, LIFE Study Group. Cardiovascular morbidity and mortality in the
Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against
atenolol. Lancet 2002;359:995-1003.
36 Système cardiovasculaire